1. Home
  2. LGVN vs JNVR Comparison

LGVN vs JNVR Comparison

Compare LGVN & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • JNVR
  • Stock Information
  • Founded
  • LGVN 2014
  • JNVR 2018
  • Country
  • LGVN United States
  • JNVR United States
  • Employees
  • LGVN N/A
  • JNVR N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • JNVR Finance: Consumer Services
  • Sector
  • LGVN Health Care
  • JNVR Finance
  • Exchange
  • LGVN Nasdaq
  • JNVR Nasdaq
  • Market Cap
  • LGVN 7.8M
  • JNVR 8.9M
  • IPO Year
  • LGVN 2021
  • JNVR 2023
  • Fundamental
  • Price
  • LGVN $3.30
  • JNVR $0.75
  • Analyst Decision
  • LGVN Strong Buy
  • JNVR
  • Analyst Count
  • LGVN 1
  • JNVR 0
  • Target Price
  • LGVN $12.00
  • JNVR N/A
  • AVG Volume (30 Days)
  • LGVN 11.1M
  • JNVR 1.0M
  • Earning Date
  • LGVN 08-09-2024
  • JNVR 07-16-2024
  • Dividend Yield
  • LGVN N/A
  • JNVR N/A
  • EPS Growth
  • LGVN N/A
  • JNVR N/A
  • EPS
  • LGVN N/A
  • JNVR N/A
  • Revenue
  • LGVN $978,000.00
  • JNVR $1,947,052.00
  • Revenue This Year
  • LGVN $137.24
  • JNVR N/A
  • Revenue Next Year
  • LGVN $50.77
  • JNVR N/A
  • P/E Ratio
  • LGVN N/A
  • JNVR N/A
  • Revenue Growth
  • LGVN N/A
  • JNVR N/A
  • 52 Week Low
  • LGVN $0.77
  • JNVR $0.70
  • 52 Week High
  • LGVN $36.50
  • JNVR $5.50
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 55.46
  • JNVR 38.25
  • Support Level
  • LGVN $3.36
  • JNVR $0.71
  • Resistance Level
  • LGVN $4.88
  • JNVR $0.80
  • Average True Range (ATR)
  • LGVN 0.66
  • JNVR 0.09
  • MACD
  • LGVN 0.11
  • JNVR 0.00
  • Stochastic Oscillator
  • LGVN 35.63
  • JNVR 5.58

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

Share on Social Networks: